Abstract:Abstract Background: To investigate whether a series of biomarkers including club cell protein 16 (CC16), angiopoietin 2(Ang-2), soluble receptor for advanced glycation end-products (sRAGE), high-mobility group box 1 protein (HMGB1), and surfactant protein D (SPD) could be utilized for identifying patients, thereby increasing the diagnostic value of acute respiratory distress syndrome(ARDS) in intensive care unit (ICU). Methods: 211 ICU admissions were enrolled in this retrospective, nested case-control study. These patients were then divided into ARDS (n=79) and non-ARDS (n=132) groups according to the Berlin criteria on ICU day 1. Patient characteristics, vital signs, and laboratory examinations were collected within three hours of admission. Five inflammatory associated plasma biomarkers, as well as lung epithelial and endothelial injury which included CC16, Ang-2, sRAGE, HMGB1 and SPD were measured in the morning of day two in the ICU. Diagnostic values were analyzed with receiver operating characteristic (ROC) curves. Pearson’s product-moment correlation coefficient and multivariate logistic regression analysis were applied for predictive purposes. Results: C-reactive protein (CRP), NT-proBNP, and PH values for traditional indicators and five biomarkers were analyzed with an objective ARDS indicator, the PaO2/FiO2 ratio. Evidence suggests that only four of potential indicators analyzed here, and CRP hold high diagnostic value. The area under curve (AUC) for each were as follows: CC16 (AUC: 0.752; 95%CI0.680-0.824), Ang-2 (AUC: 0.695; 95%CI 0.620 -0.770), HMGB1 (AUC: 0.668; 95%CI 0.592-0.744), sRAGE (AUC: 0.665; 95%CI 0.588-0.743), CRP (AUC: 0.701; 95%CI 0.627-0.776). No single indicator surpassed the diagnostic capability of the PaO2/FiO2 ratio which had an AUC: 0.844(95%CI 0.789-0.898), especially in terms of sensitivity. However, when the binary logistic model was transformed and the model was built, the AUC increased from 0.647(95%CI 0.568-0.726) to 0.911(95%CI 0.864-0.946). Among the combinations tested, PaO2/FiO2+CRP+Ang-2+CC16+HMGB1 resulted in an AUC of 0.910 (95%CI 0.863-0.945), while PaO2/FiO2+CRP+Ang-2+CC16+HMGB1+sRAGE+SPD have an AUC of 0.911(95%CI 0.864-0.946). Conclusions: A combination of the assessed biomarkers could enhance ARDS diagnostics, which has obvious ramifications for patient care and prognosis. It may be possible to develop a predictive ARDS nomogram; however, of the combinations tested here, we would recommend PaO2/FiO2+CRP+Ang-2+CC16+HMGB1 for clinical practice. This is because of the cost implications in contrast with the benefit involved in utilizing the more elaborate model. Although, further health economics research is required to consider this opportunity cost for emergency care policy.

Octane in exhaled breath to diagnose acute respiratory distress syndrome in invasively ventilated intensive care unit patients

Breath octane and acetaldehyde as markers for acute respiratory distress syndrome in invasively ventilated patients suspected to have ventilator-associated pneumonia

Systematic review of diagnostic methods for acute respiratory distress syndrome

Exhaled Breath and Oxygenator Sweep Gas Propionaldehyde in Acute Respiratory Distress Syndrome

Breath metabolomics for diagnosis of acute respiratory distress syndrome

The ROX index can be a useful tool for the triage evaluation of COVID-19 patients with dyspnoea

Correlation Between Nitric Oxide Content in Exhaled Breath Condensate and the Severity of Acute Respiratory Distress Syndrome.

Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease

A Retrospective, Nested Case-Control Study to Develop a Biomarker-Based Model for ARDS Diagnostics

Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study

Enhancing-ARDS diagnostics for ICU patients: a retrospective, nested case-control study to develop a biomarker-based model

Accuracy of the Radiographic Assessment of Lung Edema Score for the Diagnosis of ARDS

Breath analysis for detection and trajectory monitoring of acute respiratory distress syndrome in swine

Predicting the early incidence and stratification of acute respiratory distress syndrome (ARDS) using alveolar-arterial oxygen partial pressure difference (AaDO2): A retrospective study from the MIMIC-IV database

Breath Analysis via Gas Chromatography-Mass Spectrometry (GC-MS) in Chronic Coronary Syndrome (CCS): A Proof-of-Concept Study

Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease

Validation of a Novel Molecular Host Response Assay to Diagnose Infection in Hospitalized Patients Admitted to the ICU With Acute Respiratory Failure

Initial oxygenation as early predictor of mortality in acute respiratory distress syndrome: a retrospective study

LIPS and PaO 2 /FiO 2 Combined Plasma Biomarkers Predict Onset of Acute Respiratory Distress Syndrome in Patients of High Risks in SICU: A Prospective Exploratory Study

Respiratory drive heterogeneity associated with systemic inflammation and vascular permeability in acute respiratory distress syndrome

Rapid breath analysis for acute respiratory distress syndrome diagnostics using a portable two-dimensional gas chromatography device